Citation: | WANG H M, LI J L, DONG Y Q, et al. Computer Tomography Features of Antineutrophil Cytoplasm Antibody-associated Vasculitis-interstitial Lung Disease and Its Correlation with Antineutrophil Cytoplasmic Antibody Concentration[J]. CT Theory and Applications, 2025, 34(4): 604-610. DOI: 10.15953/j.ctta.2025.081. (in Chinese). |
This study systematically analyzed the CT imaging features of patients diagnosed with ANCA-associated vasculitis (AAV)-related interstitial lung disease (ILD) at the time of their first diagnosis. The types and distribution characteristics of the lesions and their correlation with laboratory findings were investigated. A retrospective study was conducted on 92 patients with newly diagnosed AAV-ILD. Clinical and CT imaging data were collected. CT imaging data were analyzed qualitatively and quantitatively to evaluate lesion types (e.g., ground-glass opacities, reticulations, honeycombing, consolidation, and traction bronchiectasis) and their distribution patterns. The severity of the lesions was quantified using a pulmonary fibrosis scoring system, and the correlation between imaging features and laboratory indices was analyzed. AAV-ILD was more commonly observed in elderly male patients. Honeycombing and reticulations were the most common CT-imaging findings, with lesions primarily distributed in the bilateral lower lungs and peripheral regions. AAV-ILD predominantly exhibited a usual interstitial pneumonia (UIP) pattern. A significant positive correlation was also observed between the pulmonary fibrosis score and myeloperoxidase (MPO) concentration and between honeycombing scores and MPO concentration. The CT features of AAV-ILD are unique. The correlation between MPO and pulmonary fibrosis suggests that MPO may serve as a potential biomarker for the progression of pulmonary fibrosis. These findings provide important insights into the imaging characteristics and pathological mechanisms of AAV-ILD.
[1] |
SEBASTIANI M, MANFREDI A, VACCHI C, et al. Epidemiology and management of interstitial lung disease in ANCA-associated vasculitis[J]. Clinical and Experimental Rheumatology, 2020, 124(2): 221-231.
|
[2] |
SACOTO G, BOUKHLAL S, SPECKS U, et al. Lung involvement in ANCA-associated vasculitis[J]. Presse Médicale, 2020, 49(3): 104039. DOI: 10.1016/j.lpm.2020.104039.
|
[3] |
刘泠钰, 田新平. 原发性系统性血管炎的肺部表现[J]. 中华医学杂志, 2021, 101(24): 1938-1941.
LIU L Y, TIAN X P. Pulmonary manifestations of primary systemic vasculitis. Chinese Medical Journal, 2021, 101(24): 1938-1941. (in Chinese).
|
[4] |
DOLINER B, RODRIGUEZ K, MONTESI S B, et al. Interstitial lung disease in ANCA-associated vasculitis: Associated factors, radiographic features and mortality[J]. Rheumatology (Oxford), 2023, 62(2): 716-725. DOI: 10.1093/rheumatology/keac339.
|
[5] |
马震忠, 盛亚丹, 杨凯, 等. 皮肌炎/多发性肌炎相关间质性肺病高分辨率CT特征[J]. CT理论与应用研究(中英文), 2024, 33(4): 497-502. DOI: 10.15953/j.ctta.2023.131.
MA Z Z, SHENG Y D, YANG K, et al. HRCT features of dermatomyositis-/polymyositis- associated interstitial lung disease[J]. CT Theory and Applications, 2024, 33(4): 497-502. DOI: 10.15953/j.ctta.2023.131. (in Chinese).
|
[6] |
HINO T, LEE KS, YOO H, et al. Interstitial lung abnormality (ILA) and nonspecific interstitial pneumonia (NSIP)[J]. European Journal of Radiology Open, 2021, 8: 100336. DOI: 10.1016/j.ejro.2021.100336.
|
[7] |
DELANEY L, ALABED S, MAITER A, et al. Meta-analysis of interobserver agreement in assessment of interstitial lung disease using high-resolution CT[J]. Radiology, 2024, 313(1): e240016. DOI: 10.1148/radiol.240016.
|
[8] |
TURGEON D, BALTER M S, PAGNOUX C. Interstitial lung disease in patients with anti-neutrophil cytoplasm antibody-associated vasculitis: An update on pathogenesis and treatment[J]. Current Opinion in Pulmonary Medicine, 2023, 29(5): 436-442. DOI: 10.1097/mcp.0000000000000979.
|
[9] |
ALBA M A, FLORES-SUÁREZ L F, HENDERSON A G, et al. Interstitial lung disease in ANCA vasculitis[J]. Autoimmunity Reviews, 2017, 16(7): 722-729. DOI: 10.1016/j.autrev.2017.05.008.
|
[10] |
MCDERMOTT G, FU X, STONE J H, et al. Association of cigarette smoking with antineutrophil cytoplasmic antibody-associated vasculitis[J]. JAMA Internal Medicine, 2020, 180(6): 870-876. DOI: 10.1001/jamainternmed.2020.0675.
|
[11] |
CERRO-CHIANG G, AYRES M, RIVAS A, et al. An exploratory analysis of differences in serum protein expression by sex in patients with systemic sclerosis associated interstitial lung disease[J]. BMC Pulmonary Medicine, 2025, 25(1): 16. DOI: 10.1186/s12890-024-03474-z.
|
[12] |
HUNNINGHAKE G M, HATABU H, OKAJIMA Y, et al. MUC5B promoter polymorphism and interstitial lung abnormalities[J]. New England Journal of Medicine, 2013, 368(23): 2192-2200. DOI: 10.1056/NEJMoa1216076.
|
[13] |
CHOI W I, DAUTI S, KIM H J, et al. Risk factors for interstitial lung disease: A 9-year nationwide population-based study[J]. BMC Pulmonary Medicine, 2018, 18(1): 96. DOI: 10.1186/s12890-018-0660-2.
|
[14] |
KADURA S, RAGHU G. Antineutrophil cytoplasmic antibody-associated interstitial lung disease: A review[J]. European Respiratory Review, 2021, 30(162). DOI: 10.1183/16000617.0123-2021.
|
[15] |
OIWA H, OOI K, OYAMA T, et al. Idiopathic interstitial pneumonia as a possible cause of antineutrophil cytoplasmic antibody-associated vasculitis: A case report[J]. Archives of Rheumatology, 2018, 33(1): 89-92. DOI: 10.5606/ArchRheumatol.2018.6532.
|
[16] |
NEGREROS M, FLORES-SUÁREZ L F. A proposed role of neutrophil extracellular traps and their interplay with fibroblasts in ANCA-associated vasculitis lung fibrosis[J]. Autoimmunity Reviews, 2021, 20(4): 102781. DOI: 10.1016/j.autrev.2021.102781.
|
[17] |
LEE KS, HAN J, WADA N, et al. Imaging of pulmonary fibrosis: An update, from the AJR special series on imaging of fibrosis[J]. American Journal of Roentgenology, 2024, 222(2): e2329119. DOI: 10.2214/ajr.23.29119.
|
[18] |
WIJSENBEEK M, SUZUKI A, MAHER T M. Interstitial lung diseases[J]. Lancet, 2022, 400(10354): 769-786. DOI: 10.1016/s0140-6736(22)01052-2.
|
[19] |
BANKIER A A, MACMAHON H, COLBY T, et al. Fleischner society: Glossary of terms for thoracic imaging[J]. Radiology, 2024, 310(2): e232558. DOI: 10.1148/radiol.232558.
|
[20] |
HATA A, HINO T, PUTMAN R K, et al. Traction bronchiectasis/bronchiolectasis on CT scans in relationship to clinical outcomes and mortality: The COPD Gene study[J]. Radiology, 2022, 304(3): 694-701. DOI: 10.1148/radiol.212584.
|
[21] |
SMITH M L. The histologic diagnosis of usual interstitial pneumonia of idiopathic pulmonary fibrosis: Where we are and where we need to go[J]. Modern Pathology, 2022, 35(S1): 8-14. DOI: 10.1038/s41379-021-00889-5.
|
[22] |
张笑雨, 于文成, 冯爱然, 等. ANCA血管炎相关间质性肺病的研究进展[J]. 青岛大学学报(医学版), 2018, 54(1): 115-118,126.
ZHANG X Y, YU W C, FENG A R, et al. Research progress of ANCA vasculitis-related interstitial lung disease[J]. Journal of Qingdao University (Med Edition), 2018, 54(1): 115-118,126. (in Chinese).
|
[23] |
SALVATI L, PALTERER B, LAZZERI E, et al. Presentation and progression of MPO-ANCA interstitial lung disease[J]. Journal of Translational Autoimmunity, 2024, 8: 100235. DOI: 10.1016/j.jtauto.2024.100235.
|
[24] |
HOSODA C, BABA T, HAGIWARA E, et al. Clinical features of usual interstitial pneumonia with anti-neutrophil cytoplasmic antibody in comparison with idiopathic pulmonary fibrosis[J]. Respirology, 2016, 21(5): 920-926. DOI: 10.1111/resp.12763.
|
[1] | HEI He, YANG Kai, HE Liyu, SHENG Yadan, YAN Yaqi, ZHU Bingjie, ZHANG Yuting, TONG Jiayin, ZHANG Jingping, JIN Chenwang. Quantitative CT Analysis of Lung Features in Patients with Polymyositis/Dermatomyositis without Interstitial Lung Disease[J]. CT Theory and Applications, 2025, 34(4): 580-588. DOI: 10.15953/j.ctta.2025.114 |
[2] | MA Zhenzhong, SHENG Yadan, YANG Kai, HE Liyu, HAN Tingting, TONG Jiayin, ZHANG Jingping, JIN Chenwang. HRCT Features of Dermatomyositis-/Polymyositis- Associated Interstitial Lung Disease[J]. CT Theory and Applications, 2024, 33(4): 497-502. DOI: 10.15953/j.ctta.2023.131 |
[3] | LIU Rui, WU Tingting, GOU Shaobo, XUE Ruihong, JIA Yanru, CHAI Jun. Clinical Application Potentials of Ground Glass Opacities in Different Stages of Coronavirus Disease 2019[J]. CT Theory and Applications, 2023, 32(3): 339-346. DOI: 10.15953/j.ctta.2023.046 |
[4] | YIN Ke, ZHOU Rongyu, WU Jianlin. The Research Progress of HRCT-based Diagnostic Models for Differentiating Infiltration Degree of Pure Ground Glass Nodular Lung Adenocarcinoma[J]. CT Theory and Applications, 2020, 29(5): 621-629. DOI: 10.15953/j.1004-4140.2020.29.05.14 |
[5] | LIU Yongbin, CHEN Huai, ZENG Qinsi, LI Jianqin. Chest CT and Clinical Characteristics of COVID-19 Patients with Multiple Ground Glass Shadows[J]. CT Theory and Applications, 2020, 29(3): 289-294. DOI: 10.15953/j.1004-4140.2020.29.03.04 |
[6] | LIU Li-wei, ZHANG Long-jiang, QIAN Bin. 3D CT Value Analysis of Ground Glass Shadow and Coelentereous Growth in Stage Ⅰ Invasive Lung Adenocarcinoma[J]. CT Theory and Applications, 2018, 27(1): 115-121. DOI: 10.15953/j.1004-4140.2018.27.01.15 |
[7] | WANG Hui, LIU Hong, HUANG Hai-dong, ZHAO Rui. Comparative Analysis of MSCT Features and Pathology of Ground-glass Nodules of Lung Adenocarcinomas[J]. CT Theory and Applications, 2018, 27(1): 93-99. DOI: 10.15953/j.1004-4140.2018.27.01.12 |
[8] | PENG Hao, HU Jun-jiao, HUANG Lin-wen, MOU Shu-fang, XU Jian-bo, ZHOU Ying-ying, PAN Xiao-huan, LI Jing-xu, YANG Xin-guan, GUAN Yu-bao. CT Findings of Lung Adenocarcinoma in Situ on High-resolution Computed Tomography[J]. CT Theory and Applications, 2017, 26(5): 583-589. DOI: 10.15953/j.1004-4140.2017.26.05.07 |
[9] | YAN Ying-nan, ZHANG Su-yan, YU Tie-feng, ZHAO Hong-xia, LIU Rong-hua. Imaging Features of Lung Focal Ground-glass Opacities on MDCT after Thin-section (1mm) Reconstruction[J]. CT Theory and Applications, 2017, 26(2): 203-210. DOI: 10.15953/j.1004-4140.2017.26.02.09 |
[10] | BAO Ya-hong, CHENG Gang. CT Diagnosis and Follow-up Analysis of Lung Cancer as Ground-glass Opacity[J]. CT Theory and Applications, 2016, 25(2): 219-225. DOI: 10.15953/j.1004-4140.2016.25.02.13 |